It is a weekly injection tailored for individuals with a BMI of 30 or above, or 27 or higher if accompanied by weight-related health issues
GLP-1 drugs were originally developed to treat diabetes and obesity
In March 2025, Novo Nordisk CEO Lars Fruergaard Jrgensen told Bloomberg that he expected to see some short-term impact from the tariffs
A 2020 study in Nutrients found that hydrolyzed collagen peptides stimulated GLP-1 secretion in human enteroendocrine cells
These deficiencies affect the nervous system, weaken bones and muscles, and disrupt immunity
Culturally, we have rituals around food that bring us joy and fond memories," Rachel Goldman, a New York City psychologist who specializes in weight management, said